Cargando…
Cardiotoxicity, Cardioprotection, and Prognosis in Survivors of Anticancer Treatment Undergoing Cardiac Surgery: Unmet Needs
SIMPLE SUMMARY: Cardiovascular (CV) risk factors and disease are increasingly reported among survivors of anticancer treatments as those treatments are effective in improving prognosis in patients affected by malignancy. It is unclear the extent to which drugs used in general population to prevent i...
Autores principales: | Palmieri, Vittorio, Vietri, Maria Teresa, Montalto, Andrea, Montisci, Andrea, Donatelli, Francesco, Coscioni, Enrico, Napoli, Claudio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10137207/ https://www.ncbi.nlm.nih.gov/pubmed/37190153 http://dx.doi.org/10.3390/cancers15082224 |
Ejemplares similares
-
Cardiac Toxicity Associated with Cancer Immunotherapy and Biological Drugs
por: Montisci, Andrea, et al.
Publicado: (2021) -
Severe Cardiac Toxicity Induced by Cancer Therapies Requiring Intensive Care Unit Admission
por: Montisci, Andrea, et al.
Publicado: (2021) -
Big Data in cardiac surgery: real world and perspectives
por: Montisci, Andrea, et al.
Publicado: (2022) -
Veno-arterial Extracorporeal Membrane Oxygenation as Bridge to Heart Transplantation: The Way Forward
por: Montisci, Andrea, et al.
Publicado: (2021) -
Epigenetic Therapies for Heart Failure: Current Insights and Future Potential
por: Napoli, Claudio, et al.
Publicado: (2021)